ABSTRACT BACKGROUND: Our objective was to identify the risk factors associated with placenta accreta. METHODS: Cases of peripartum hysterectomy at University Hospital of Bratislava were identifi ed in the period from January 1st 2008 to December 31th 2013. Included were only those cases which had a histological evidence of placenta accreta. RESULTS: Fifty patients, who underwent peripartum hysterectomy were included in the study. Between 2008 and 2013 eight cases of placenta accreta were identifi ed. Five (62.5 %) of these were suspected before delivery. The overall incidence of PA was 0.19 per 1000 deliveries. Median gestational age at delivery was 37 weeks (range 25-41 weeks). Six of eight (75 %) women with placenta accreta had a previous caesarean delivery or curettage. In 5 patients both placenta praevia and prior Caesarean delivery were present. Among the 50 women who underwent peripartum hysterectomy, 8 (16 %) were patients with both prenatally diagnosed placenta praevia and previous caesarean delivery, placenta accreta was suspected in 4 of these (50 %) compared with 10 of 42 (24 %) without this combination of risk factors. CONCLUSIONS: Those in whom placenta accreta was suspected were delivered earlier than 37 weeks of gestation and were less likely to have emergency delivery. Placenta accreta is the second most common indication for an emergency peripartum hysterectomy. There is a high suspicion of placenta accreta in patients with placenta praevia and after previous Caesarean section ( Tab. 3, Ref. 17). Text in PDF www.elis.sk.
Introduction
Placenta accreta (PA) is a severe obstetric complication associated with considerable maternal morbidity, such as large volume blood transfusion, peripartum hysterectomy, cystotomy, intensive care unit admission, wound infection and prolonged hospitalization (1, 2) . PA is an abnormal invasion of chorionic villi into myometrium, with diffi cult separation of these two tissues after delivery. The nosologic entity is divided into three grades based on histopathology: placenta accreta, increta and percreta, because they could often not be safely distinguished from one another macroscopically (1) . The exact pathogenesis of placenta accreta is unknown. The expert hypothesis includes a maldevelopment of decidua, excessive trophoblastic invasion, or a combination of both (3) . Major risk factors for developing of placenta accreta include placenta praevia and prior Caesarean delivery (CS) (4) . Countries with high CS incidence, such as Cyprus and Italy, are observing an increasing incidence (5) . Other risk factors are maternal age (more then 35 years), multiparity, Asherman`s syndrome, smoking, chronic hypertension and history of gynecologic procedure (such as curretage, myomectomy, salpinectomy due to GEU) and IVF. Up to 88 % of women with PA have concomitant placenta praevia (6, 7) . PA has become the leading cause of emergency hysterectomy (8) .
The reported incidence of placenta accreta is approximately 1:1000 deliveries, ranging from 0.04 % to 0.9 %. The incidence of PA varies widely, mainly due to differences in diagnostic criteria of PA and characteristics of studied population (3) . Recent studies estimate the maternal mortality related to PA to approximately 7 % and morbidity about 60 % (3). Ultrasound diagnosis of PA is sometimes possible in the fi rst trimester by experienced sonographer (9) . In the fi rst trimester low-lying gestational sac attached to a uterine scar can be observed on ultrasound. Ultrasound characteristics during the second and third trimester are described as loss of continuity of the uterine wall, multiple vascular lacunes within placental tissue giving the "Swiss cheese" appearance to the adjacent site of placental implantation site. Other ultrasound characteristics are lack of a hypoechogenic border (myometrial zone) between the placenta and the myometrium, bulging of the placental/myometrial site into the bladder, and increased vasculature evident on color Doppler sonography. Magnetic resonance imaging (MRI) is also effective in prenatal diagnosis, and is useful in the case of inconclusive fi ndings (10, 11) . Elevated biochemical markers such as alpha fetoprotein and human chorionic gonadotropin within the triple screening test have been reported to be associated with an increased risk of placenta accreta (12) . Women with placenta accreta usually deliver by a caesarean section, during which elective hysterectomy is usually performed in order to reduce maternal morbidity. Nevertheless, in recent years, more conservative management strategies are being examined to potentially minimize surgical involvement and to preserve women's fertility. The primary idea of conservative management is to leave the placenta in situ during the caesarean delivery. Conservative management is associated with a lower risk of hemorrhage and lower hysterectomy rate, but a higher risk of maternal infection (13) . A retrospective, multicentric study of conservative management of placenta accreta reported a success rate of 80 % (3).
Materials and methods
In our study we included patients in whom peripartum hysterectomy was carried out due to placenta accreta, at the Department of Gynecology and Obstetrics, University Hospital Bratislava, from January 1st 2008 until December 31st 2013. Medical records were reviewed for clinical history of patients especially obstetric and gynaecological anamnesis, antepartum and intrapartum management, maternal morbidity during hospitalization, neonatal admissions to intensive care unit and outcomes. Laboratory investigations and histopathological results were reviewed via the hospital database system. Diagnosis had to be based on clinical and histopathological fi ndings of placental invasion into the myometrium. Early morbidity was defi ned as the occurrence of one or more of the following: maternal admission to the intensive care unit (ICU) for more than 24 hours, transfusion of ≥ 4 units of packet red blood cells (PRBC), coagulopathy (platelets ≤ 100 000/ μL, international normalized ratio ≥ 1.2, and/or fi brinogen ≤ 200 mg/dl), urinary tract injury and early re-operation. Late morbidity was defi ned as intra-abdominal (persistent fever, leukocytosis, abdominal pain) or wound infection. Results are expressed as raw numbers or median (range). The statistical analysis of data was performed using Student's t test, chi-square analysis and Fisher's exact test.
Results
During the studied time period there were 46 102 deliveries. 50 cases of peripartum hysterectomies were performed, from which 8 patients were diagnosed with PA histologically. The overall incidence of peripartum hysterectomy during this period was 1.08/1000 deliveries. The PH ratio increased during the study period, being 0.6/1000 in 2008 and 1.6/1000 deliveries in 2013. The total CS rate was 37.27 %, with a raise from 33 % (2008) to 41 % (2013). The primary indications for hysterectomy were uncontrolled bleeding caused by uterine hypotony (40 %), followed by placenta praevia (20 %) and placenta accreta (16 %). The incidence of PA was 0.19 per 1000 deliveries over the 6-years period. Table 1 illustrates maternal characteristics of our study population. Table 2 describes management of women with placenta accreta. Fourteen women (28 %) had prenatally identifi able risk factors for placenta accreta. Five (36 %) of them underwent MRI which did not exclude PA. All women had at least one prenatal ultrasound examination performed. Postpartum by the histological examination, the placenta accreta was found in 8 patients. In four cases placenta praevia with placenta accreta were present, there were two cases of placenta increta, one placenta praevia with placenta percreta and one placenta accreta. In the case of prenatal diagnosis, 64 % of patients had a concomitant placenta praevia. Six of eight (75 %) women with placenta accreta had a previous caesarean delivery or curettage. Of the PA cases, three women delivered vaginally (all of them had an undiagnosed placenta accreta). Five women delivered by caesarean section. Elective caesarean section was done in four patients (80 %). Emergency caesarean section was performed in 1 (20 %) case, at 27th week of gestation because of intensive vaginal bleeding. From the 14 women with suspected placenta accreta, 10 (71 %) underwent hysterectomy at the time of delivery. The mean gestational age for elective caesarean deliveries among women with prenatally suspected placenta accreta was 37.75 weeks (range 37-40 weeks). There was only one case of emergency caesarean delivery at 27th week of gestation and this newborn required neonatal ICU admission.
Mean estimated blood loss of the PA cases was 2.35 ± 1.178 l (range 1000-5000). Estimated blood loss < 1,000 ml occurred in 1 case (12.5 %); 1,000-1,999 ml in 1 case (12.5 %); 2,000-3,000 ml in 5 cases (62.5 %); 5,000 ml in 1 case (12.5 %). The median PRBC transfusion requirement was 6 ± 2.264 units. The amount of units of PRBC transfusions required by patients with PA is shown in Table 3 . Nearly two-thirds of women with prenatally suspected placenta accreta required at least four units of PRBC transfusion. We found a nonsignifi cant reduction of mean blood loss of 0.500 l, when elective hysterectomy was done compared to emergency hysterectomy (p < 0.580). Early morbidity in our study group was 72 % (10 women). Among cases of placenta accreta there was only one ureteral injury, which occurred in women without preoperatively placed bilateral ureteric stent. This case of ureteral injury happened during elective caesarean delivery in a patient with placenta percreta. Infectious complications only occurred in one case. There was one case of placenta percreta that required reoperation within 24 hours of delivery because of intraabdominal hemorrhage. The median postoperative length of hospital stay due to PA was 6.5 (range 1-13) days. Postoperative hospital stay was longer than 7 days in 4 (50 %) patients with PA.
The relation between previous caesarean section and PA was as follows: 6 cases of PA were in patients without previous caesarean section, 1 in patient with history of one previous caesarean section and 1 case of patient with two previous caesarean sections. From the 50 cases of peripartum hysterectomies done in this time period, there were thirty two total abdominal hysterectomies and eighteen subtotal hysterectomies. 11 of 14 (80 %) in the group with prenatally suspected placenta accreta required total hysterectomy compared to 62.5 % in group with histologically confi rmed cases of PA. In group of women with prenatally suspected placenta accreta eight women (60 %) were multiparous. In women who underwent peripartum hysterectomy due to placenta accreta there were non-signifi cantly lower rates of admission to the ICU (29 versus 14 %), large volume of blood transfusion (71 versus 75 %), bladder injury (7 versus 11%) and intra-abdominal infection (7 versus 8 %) compared to women after peripartum hysterectomy for other reasons. Women with suspected placenta accreta had more frequently elective caesarean delivery than emergency caesarean delivery (50 versus 14 %). Table 3 shows early and late morbidity for women with prenatally suspected placenta accreta. Prenatal ultrasound examination that suspected placenta accreta was verifi ed by histological examination in signifi cant number of cases (p ≤ 0.014). PA was suspected on ultrasound in 5 of 8 cases and falsely diagnosed in 9 cases. Therefore, the sensitivity, specifi city, positive value, and negative predictive value was 62.5 %, 80 %, 35.7 %, 91.7 %, respectively.
No maternal or neonatal mortality was recorded. Regarding neonatal outcomes, the median gestational age at birth was 37 weeks with a birthweight of 2950g. All were singleton pregnancies, 1 of them was of IVF-achieved pregnancy. Three neonates had a low birthweight of less than 2500 g.
Discussion
The incidence of placenta accreta during the study period was 0.02 %; 1 case per 5000 deliveries. These fi ndings are similar to those reported by Fitzpatrick at al., who reported incidence of placenta accreta in their establishment in 0.17 per 1000 pregnancies (14) . Eller at al. reported incidence of placenta accreta in 0.83 cases per 1000 deliveries, with increasing ratio, 120 % over the 12-year period (4).
We found placenta accreta to be the second most common indication for an emergency peripartum hysterectomy. Miller et al. reported placenta accreta to be the most common indication for an emergency peripartum hysterectomy (6) .
The reason for increasing rate of placenta accreta is attributed to the increasing rate of caesarean births, uterine currettages and successful treatment of uterine atony with uterine drugs (15) . We observed also that 75 % of patients of PA in this study had a history of previous caesarean section or currettage, and 64 % of patients had a concomitant placenta praevia. One published retrospective cohort study of 122 women with placenta praevia, included 25 women with PA, of which 96 % had a history of previous caesarean section (16 (7) 1 (7) 1 (7) 4 (11) 0 (0) (79) 2 (14) 3 (8) 22 (61) 11 (31) Early morbidity Late morbidity 10 (71) 1 (7) 30 (83) 3 (8) Date are given as median (range) or n (%) Tab. 3. Early and late morbidity in women with prenatally suspected placenta accreta.
Among the 50 women who underwent peripartum hysterectomy and were included in our study, 14 (28 %) women were both multigravidae and multiparous (≥ 3) of which placenta accreta was suspected in 6 (43 %) women, compared to 8 of 36 (22 %) women without this combination of risk factors. These results refl ect that multiparous women are more likely to have placenta accreta than primiparous. Nevertheless, of 5 (10 %) patients with both placenta praevia and prior caesarean delivery, 2 (40 %) cases had suspected placenta accreta compared with 14 of 45 (27 %) without this combination of risk factors. Murphy et al. reported a signifi cant association between placenta praevia and prior caesarean section in cases of suspected placenta accreta (93 %) (17) .
The incidence of placenta accreta was 0.01% in women less than 35 years old, and 0.1 % in women over 35 years old. Among women with placenta praevia, which delivered during the study period, placenta accreta was verifi ed in 5 of 156 women (3 %).
Miller et al showed that placenta accreta occurred in 55 of 590 (9.3%) women with placenta previa. They reported 2 % risk of placenta praevia accreta for women younger than 35 years without previous history of caesarean section (6) .
Overall, the morbidity in the group of women with suspected placenta accreta was similar to that of group of women with unsuspected placenta accreta. Major morbidity was observed in 92 % of cases (33 women) in a group of unsuspected placenta accreta. Overall median estimated blood loss in cases of placenta accreta was 2,100 mL and median PRBC transfusion was 6 units, with a loss of ≥ 2,000 mL in 62.5 % and a loss of ≥ 5,000 mL in 12.5 % of cases. Kassem et al reported a median blood loss of 2,000 mL and a median PRBCs transfusion requirement of 6 units in 25 patients undergoing hysterectomy for PA (16) . Another study of 77 patients with PA reported median blood loss of 3,000 ml and median PRBCs transfusion of 5 units (18). Nearly one third of women with suspected placenta accreta in this study required admission to an ICU. These observations are consistent with the high morbidity reported in other cases of placenta accreta (4) .
Gray scale ultrasonography is usually suffi cient to diagnose PA, with a reported sensitivity of 83 %, specifi city of 94 %, a positive predictive value of 81 %, and negative predictive value of 95 % (16). Our data showed the sensitivity of grayscale USG 63 % and specifi city of 80 %. The reason for only 36 % positive predictive value is for the small number of PA cases, with 3 undiagnosed cases in a patient without history of previous caesarean section or concomitant placenta praevia.
The median gestational age at delivery in women with suspected placenta accreta was 37 (range 27-41) weeks compared to 39 (range 27-41) weeks in a group of women after peripartum hysterectomy for other reason. Those in whom placenta accreta was suspected, delivered earlier and were multiparous (≥ 3). Despite these facts women undergoing peripartum hysterectomy due to placenta accreta had insignifi cantly lower rates of early and late morbidity. Recent studies suggested that planned caesarean delivery (32th -34th weeks of gestation) and hysterectomy at an early gestation to avoid emergency delivery may reduce maternal morbidity. If elective delivery was performed at 34 weeks of gestation then approximately 30 % of emergency deliveries have been avoided. The potential maternal benefi ts of earlier delivery must be with agreement with the consequences of premature birth (4) .
Women who underwent peripartum hysterectomy due to placenta accreta had higher rates of elective caesarean delivery (50 versus 36 %) than women after peripartum hysterectomy for other reason. Women with placenta percreta were more likely to require additional PRBC transfusion, suffer renal tract injury and require intensive care admission than women with placenta accreta or increta. One-third of women with postnatally verifi ed placenta accreta suffered from surgical complications, mostly from urinary tract injuries. Women with unsuspected placenta accreta had an insignifi cant increase in early morbidity compared with women with a prenatal diagnosis of placenta accreta (83 versus 71 %). These fi ndings are similar to those reported by Eller et al (4) .
Four of fourteen (29 %) cases of suspected PA were not identifi ed on prenatal ultrasound scan. Of the fi ve women with suspected placenta accreta who underwent pelvic MRI, 40 % (2 patients) had a false-negative study results. In our study 9 of 14 (64 %) prenatally suspected placenta accreta cases had negative pathological examination.
This study shows clearly that signifi cant maternal morbidity is associated with placenta accreta. We included only PA cases diagnosed clinically and proved histologically. The relative rarity of PA dictated the small study size.
Conclusion
Placenta accreta is no longer a rare obstetric complication. Major risk factors include placenta praevia and previous caesarean delivery. Prenatal diagnosis of abnormal placental invasion decreases maternal and fetal morbidities and mortalities. Further studies including multiple centres and uniform diagnostic criteria are needed to identify optimal management strategies for this morbid condition.
